Correlation Between Sarepta Therapeutics and CureVac NV

Can any of the company-specific risk be diversified away by investing in both Sarepta Therapeutics and CureVac NV at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sarepta Therapeutics and CureVac NV into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sarepta Therapeutics and CureVac NV, you can compare the effects of market volatilities on Sarepta Therapeutics and CureVac NV and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sarepta Therapeutics with a short position of CureVac NV. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sarepta Therapeutics and CureVac NV.

Diversification Opportunities for Sarepta Therapeutics and CureVac NV

-0.84

Correlation Coefficient

Sarepta Therapeutics  CureVac NV

Pay attention - limited upside

The 3 months correlation between Sarepta and CureVac is -0.84. Overlapping area represents the amount of risk that can be diversified away by holding Sarepta Therapeutics and CureVac NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CureVac NV and Sarepta Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sarepta Therapeutics are associated (or correlated) with CureVac NV. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CureVac NV has no effect on the direction of Sarepta Therapeutics i.e., Sarepta Therapeutics and CureVac NV go up and down completely randomly.

Pair Corralation between Sarepta Therapeutics and CureVac NV

Given the investment horizon of 90 days Sarepta Therapeutics is expected to under-perform the CureVac NV. In addition to that, Sarepta Therapeutics is 1.62 times more volatile than CureVac NV. It trades about -0.12 of its total potential returns per unit of risk. CureVac NV is currently generating about 0.16 per unit of volatility. If you would invest  336.00  in CureVac NV on May 6, 2025 and sell it today you would earn a total of  205.00  from holding CureVac NV or generate 61.01% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Sarepta Therapeutics  vs.  CureVac NV

Sarepta Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Sarepta Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in September 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

CureVac NV

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in CureVac NV are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating basic indicators, CureVac NV exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Sarepta Therapeutics and CureVac NV

The main advantage of trading using opposite Sarepta Therapeutics and CureVac NV positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sarepta Therapeutics position performs unexpectedly, CureVac NV can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CureVac NV will offset losses from the drop in CureVac NV's long position.

The idea behind Sarepta Therapeutics and CureVac NV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.